Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
73,582,846
-
Share change
-
+904,627
-
Total reported value
-
$23,022,199,854
-
Put/Call ratio
-
124%
-
Price per share
-
$313.00
-
Number of holders
-
640
-
Value change
-
+$181,006,352
-
Number of buys
-
294
-
Number of sells
-
357
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2019
As of 30 Jun 2019,
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) was held by
640 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,582,846 shares.
The largest 10 holders included
Capital World Investors, VANGUARD GROUP INC, BlackRock Inc., HARRIS ASSOCIATES L P, STATE STREET CORP, LOOMIS SAYLES & CO L P, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, POLEN CAPITAL MANAGEMENT LLC, and ALLIANCEBERNSTEIN L.P..
This page lists
645
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.